| http://www.w3.org/ns/prov#value | - oglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms; HYLENEX RECOMBINANT tradenameUS7767699Dec 22, 2005Aug 3, 2010Purdue Pharma, L.P.Therapeutic agents useful for treating painUS7772206Feb 27, 2009Aug 10,
|
